Evolving Pharmacotherapies for the Treatment of Metastatic Melanoma

Por Salama, April K.S.
Publicado em 2013

Updates in Therapy for Advanced Melanoma

Por Singh, Bhavana P., Salama, April K. S.
Publicado no Cancers (Basel) (2016)

Rapid complete response of metastatic melanoma in a patient undergoing ipilimumab immunotherapy in the setting of active ulcerative colitis

Por Bostwick, A Doran, Salama, April K, Hanks, Brent A
Publicado no J Immunother Cancer (2015)

Genetic risk analysis of a patient with fulminant autoimmune type 1 diabetes mellitus secondary to combination ipilimumab and nivolumab immunotherapy

Por Lowe, Jared R., Perry, Daniel J., Salama, April K. S., Mathews, Clayton E., Moss, Larry G., Hanks, Brent A.
Publicado no J Immunother Cancer (2016)

Hazard-Rate Analysis and Patterns of Recurrence in Early Stage Melanoma: Moving towards a Rationally Designed Surveillance Strategy

Por Salama, April K. S., de Rosa, Nicole, Scheri, Randall P., Pruitt, Scott K., Herndon, James E., Marcello, Jennifer, Tyler, Douglas S., Abernethy, Amy P.
Publicado em 2013

Embracing rejection: Immunologic trends in brain metastasis

Por Farber, S. Harrison, Tsvankin, Vadim, Narloch, Jessica L., Kim, Grace J., Salama, April K. S., Vlahovic, Gordana, Blackwell, Kimberly L., Kirkpatrick, John P., Fecci, Peter E.
Publicado no Oncoimmunology (2016)

Plasma Cytokine Analysis in Patients with Advanced Extremity Melanoma Undergoing Isolated Limb Infusion

Por Shetty, Gina, Beasley, Georgia M., Sparks, Sara, Barfield, Michael, Masoud, Melanie, Mosca, Paul J., Pruitt, Scott K., Salama, April K. S., Chan, Cliburn, Tyler, Douglas S., Weinhold, Kent J.
Publicado no Ann Surg Oncol (2013)

A Multicenter Prospective Evaluation of the Clinical Utility of F-18 FDG-PET/CT in Patients With AJCC Stage IIIB or IIIC Extremity Melanoma

Por Beasley, Georgia M., Parsons, Colin, Broadwater, Gloria, Selim, M. Angelica, Marzban, Suroosh, Abernethy, Amy P., Salama, April K. S., Eikman, Edward A., Wong, Terence, Zager, Jonathan S., Tyler, Douglas S.
Publicado no Ann Surg (2012)

Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma

Por Amin, Asim, Lawson, David H., Salama, April K.S., Koon, Henry B., Guthrie, Troy, Thomas, Sajeve S., O’Day, Steven J., Shaheen, Montaser F., Zhang, Bin, Francis, Stephen, Hodi, F. Stephen
Publicado no J Immunother Cancer (2016)

A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma

Por Dummer, Reinhard, Daud, Adil, Puzanov, Igor, Hamid, Omid, Schadendorf, Dirk, Robert, Caroline, Schachter, Jacob, Pavlick, Anna, Gonzalez, Rene, Hodi, F Stephen, Cranmer, Lee D, Blank, Christian, O’Day, Steven J, Ascierto, Paolo A, Salama, April K S, Li, Nicole Xiaoyun, Zhou, Wei, Lis, Joy, Ebbinghaus, Scot, Kang, Peter S, Ribas, Antoni
Publicado no J Transl Med (2015)

Efficacy of Anti-PD-1 Agents in Acral and Mucosal Melanoma

Por Shoushtari, Alexander N., Munhoz, Rodrigo R., Kuk, Deborah, Ott, Patrick A., Johnson, Douglas B., Tsai, Katy K., Rapisuwon, Suthee, Eroglu, Zeynep, Sullivan, Ryan J., Luke, Jason J., Gangadhar, Tara C., Salama, April K. S., Clark, Varina, Burias, Clare, Puzanov, Igor, Atkins, Michael B., Algazi, Alain, Ribas, Antoni, Wolchok, Jedd D., Postow, Michael A.
Publicado no Cancer (2016)

Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database

Por Surati, Mosmi, Robinson, Matthew, Nandi, Suvobroto, Faoro, Leonardo, Demchuk, Carley, Rolle, Cleo E, Kanteti, Rajani, Ferguson, Benjamin D, Hasina, Rifat, Gangadhar, Tara C, Salama, April K, Arif, Qudsia, Kirchner, Colin, Mendonca, Eneida, Campbell, Nicholas, Limvorasak, Suwicha, Villaflor, Victoria, Hensing, Thomas A, Krausz, Thomas, Vokes, Everett E, Husain, Aliya N, Ferguson, Mark K, Karrison, Theodore G, Salgia, Ravi
Publicado em 2011